Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash flows from operating activities:
Net income (loss)	$ 9,219,037	$ 14,198,719
Adjustments to reconcile net income to net cash used in operating activities:
Amortization (accretion) of investments	(48,692)	(49,401)
Realized investment gains (losses), net	(4,780,149)	(145,046)
Change in fair value of equity securities	(8,154,629)	(20,179,879)
Unrealized trading (gains) losses included in income	470	(2,734)
Realized trading (gains) losses included in income	2,516	(10,954)
Amortization of cost of insurance acquired	172,087	178,743
Depreciation and depletion	327,883	624,797
Stock-based compensation	486,797	153,765
Charges for mortality and administration of universal life and annuity products	(1,500,108)	(1,603,750)
Interest credited to account balances	948,325	987,251
Change in accrued investment income	286,260	122,188
Change in reinsurance receivables	(21,913)	413,486
Change in policy liabilities and accruals	(1,067,549)	(1,416,401)
Change in income taxes receivable (payable)	1,049,842	(1,216,970)
Change in other assets and liabilities, net	904,101	4,260,542
Net cash used in operating activities	(2,175,722)	(3,685,644)
Proceeds from investments sold and matured:
Fixed maturities available for sale	6,021,700	505,000
Equity securities	2,517,691	541,790
Trading securities	9,501	8,492
Mortgage loans	281,974	1,212,205
Real estate	6,573,943	589,785
Notes receivable	3,844,443	322,411
Policy loans	275,914	244,121
Total proceeds from investments sold and matured	19,525,166	3,423,804
Cost of investments acquired:
Fixed maturities available for sale	(50,000)	(20,000)
Equity securities	(3,913,832)	(8,468,969)
Trading securities	(8,311)	(4,232)
Mortgage loans	(1,546,165)	(387,039)
Real estate	(1,680,959)	(780,781)
Notes receivable	(2,060,657)	0
Policy loans	(207,030)	(196,034)
Total cost of investments acquired	(9,466,954)	(9,857,055)
Net cash provided by (used in) investing activities	10,058,212	(6,433,251)
Cash flows from financing activities:
Policyholder contract deposits	1,278,889	1,195,495
Policyholder contract withdrawals	(1,416,469)	(1,820,928)
Payments of principal on notes payable/line of credit	(14,000,000)	0
Purchase of treasury stock	(267,433)	(112,856)
Non controlling contributions (distributions) of consolidated subsidiary	(3)	0
Net cash used in financing activities	(14,405,016)	(738,289)
Net increase (decrease) in cash and cash equivalents	(6,522,526)	(10,857,184)
Cash and cash equivalents at beginning of period	30,787,278	39,025,754
Cash and cash equivalents at end of period	$ 24,264,752	$ 28,168,570